2023-07-31 14:33:35 ET
- Neurocrine Biosciences ( NASDAQ: NBIX ) is scheduled to announce Q2 earnings results on Tuesday, August 1st, before market open.
- The consensus EPS Estimate is $1.12 (+33.3% Y/Y) and the consensus Revenue Estimate is $447.98M (+18.5% Y/Y).
- Over the last 2 years, NBIX has beaten EPS estimates 0% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 8 upward revisions and 6 downward. Revenue estimates have seen 10 upward revisions and 8 downward.
For further details see:
Neurocrine Biosciences Q2 2023 Earnings Preview